Dechra has launched Furosoral for the initial treatment or maintenance therapy of conditions associated with fluid build-up in cats and dogs.

Furosoral contains furosemide and is indicated for the treatment of hydrothorax, hydropericardium, ascites and oedema, particularly in animals where these conditions are associated with cardiac insufficiency and renal dysfunction.

Furosoral replaces Dechra’s previous diuretic treatment, Frusedale. 

It is available in both 10 mg and 40 mg double-divisable tablets. 

The recommended daily starting dose for cats and dogs is 2.5 mg per kg of body weight.

Dechra says careful weighing is essential to ensure accurate dosing, but that the dosage can be doubled initially for severe or particularly resistant cases and adjusted to the lowest clinically effective dose for maintenance therapy if required.

Dechra companion animal brand manager, Charlotte Hill, said: “Furosoral offers a flexible treatment solution where dosage can be adjusted, depending on the needs of the patient and the underlying causes, to give vets more options for treating cats and dogs with fluid retention.

“To ensure it is as appealing to pet owners as it is to veterinary professionals, Furosoral is available in our innovative Smart Tab format, giving owners confidence that they are giving their dog or cat the right dosage and aiding compliance, leading to better outcomes for the animal.”

Furosoral 10 mg and 40 mg tablets are available in blister packs of 100 tablets for quick and easy dispensing. Divided tablets can be stored in the blister pack for up to three days, ensuring no waste.

https://www.dechra.co.uk/products/dog/prescription#/search=furosoral/. 

PS: Whilst you're here, take a moment to see our latest job opportunities for vet nurses.